Exchange: NASDAQ·Updated 07:47 PM EST

SNTI News

News
all
press releases
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Senti Biosciences (NASDAQ:SNTI) stock rose 51.8% to $0.27 during Monday's after-market session. The company's market cap stands at $5.9 million. Polyrizon (NASDAQ:PLRZ) shares increased by 14.41% toread more...
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Senti Biosciences (NASDAQ:SNTI) stock rose 51.8% to $0.27 during Monday's after-market session. The company's market cap stands at $5.9 million. Polyrizon (NASDAQ:PLRZ) shares increased by 14.41% toread more...
Benzinga
More News
Gainers Alaunos Therapeutics (NASDAQ:TCRT) stock rose 34.9% to $2.94 during Thursday's after-market session. The market value of their outstanding shares is at $7.6 million. Senti Biosciences (NASDAQ:SNTI) stockread more...
Benzinga
Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the Radoff-JEC Group or we), who collectively own approximately 7.7% of the outstanding shares of Seer, Inc. (NASDAQ: SEER) (Seer or the Company), today released a presentation detailing the urgent case for boardroom...
Business Wire
Senti Biopharma shares rallied in premarket trading on Tuesday after its cancer treatment received a positive designation from the U.S. FDA.
Stocktwits
The stock rallied to levels last seen in April 2023, drawing significant attention from retail investors.
Stocktwits

Advertisement|Remove ads.